A human killer inhibitory receptor specific for HLA-A1,2

Area of Science:

• Immunology
• Cellular Biology
• Molecular Genetics

Background:

• Killer inhibitory receptors (KIRs) are key regulators of natural killer (NK) cell and T cell-mediated cytotoxicity.
• KIRs function by binding to Major Histocompatibility Complex (MHC) class I molecules on target cells, delivering an inhibitory signal.
• While KIR interactions with HLA-B and HLA-C have been extensively studied, the repertoire of KIRs recognizing HLA-A molecules remained largely uncharacterized.

Purpose of the Study:

• To identify and characterize novel Killer Inhibitory Receptors (KIRs) involved in immune surveillance.
• To investigate the specificity of KIRs towards different Human Leukocyte Antigen (HLA) class I molecules, particularly HLA-A.
• To determine if any known KIR cDNA family members encode receptors that interact with HLA-A.

Main Methods:

• Screening of a KIR cDNA family library.
• Expression of candidate receptor proteins.
• Binding assays to confirm specificity for HLA-A3 molecules.

Main Results:

• Identification of a novel KIR cDNA family member, designated NKAT4.
• NKAT4 encodes a 70-kDa transmembrane glycoprotein.
• NKAT4 was demonstrated to specifically bind to HLA-A3, a subtype of HLA-A molecules.

Conclusions:

• The discovery of NKAT4 represents the first characterization of a KIR that specifically interacts with an HLA-A molecule.
• This finding expands the known repertoire of KIR-HLA interactions, crucial for understanding NK cell and T cell regulation.
• NKAT4 provides a new tool for investigating the role of HLA-A in immune responses and potential therapeutic strategies.